Christopher Exley, PhD, Professor in Bioinorganic Chemistry at Keele University, and Leader of the Research Group on Aluminium and Silicon, He is a Fellow of the Royal Society of Biology (FRSB), Scientific Member of the British Society of Ecological Medicine (BSEM).
Dr. Exley is recognized as a world-renowned expert on Aluminum toxicity and aluminum in the human brain. His research has been published in approximately 190 peer-reviewed journals. He has authored twelve chapters in books, and edited compilations on aluminium : aluminium in biological systems, aluminium in medicine, aluminium in Alzheimer’s disease, and aluminium in the human brain.
Dr. Exley’s publications are listed here. Dr. Exley’s most recent journal articles include:
- An Aluminium Adjuvant in a Vaccine is an Acute Exposure to Aluminium, Journal of Trace Elements in Medicine and Biology, June 2019
- A Reappraisal Of Biological Silicification In Plants? New Pytologist, 2019
- Aluminum affects neural phenotype determination of embryonic neural progenitor cells.
Archives of Toxicology, 2019
- Aluminium in Brain Tissue in Epilepsy: A Case Report… International J of Environmental Research Public Health (JERPH), 2019
- Granulomas Following Subcutaneous Injection With Aluminum Adjuvant-Containing Products in Sheep. Veterinary Pathology, 2019
- Prescription Infant Formulas Are Contaminated with Aluminium. IJERPH, 2019
- Silicic acid: The omniscient molecule. Science of the Total Environment, 2019
- Intracellular Aluminium in Inflammatory and Glial Cells in Cerebral Amyloid Angiopathy: A Case Report. International Journal of Environmental Research Public Health, 2019
- Prescription Infant Formulas Are Contaminated with Aluminium. International Journal of Environmental Research Public Health, 2019
- Egg White Hydrolysate as a functional food ingredient to prevent cognitive dysfunction in rats following long-term exposure to aluminum. Scientific Reports, 2019
- The Chemistry of Human Exposure to Aluminium. Advances in Experimental Medicine and Biology, 2018
- Unraveling The Enigma: Elucidating The Relationship Between The Physicochemical Properties Of Aluminium-Based Adjuvants And Their Immunological Mechanisms Of Action, Allergy, Asthma & Clinical Immunology, 2018
“Currently about 20 childhood vaccines include an aluminium adjuvant. The aluminium salt is the major component of a vaccine (after water) and its high content is why vaccine preparations are invariably cloudy in appearance . As an example, GlaxoSmithKline’s Infanrix Hexa vaccine is reported by the manufacturer to contain 0.82 mg of aluminium per vaccine (0.5 mL). Thus, the weight of aluminium salt in this vaccine is approximately 8 mg, which is approximately ten times the weight of all of the other components of the vaccine when combined. An aluminium-adjuvanted vaccine is essentially a very high concentration of an aluminium salt.”
Dr. Exley also blogs on The Hippocratic Post which addresses medical subjects